| 2021 | Deep-Learning-Based Natural Language Processing of Serial Free-Text Radiological Reports for Predicting Rectal Cancer Patient Survival
| FRONTIERS IN ONCOLOGY |
| 2012 | Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2011 | DNA methylation predicts recurrence from resected stage III proximal colon cancer
| CANCER |
| 2016 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
| CANCER RESEARCH AND TREATMENT |
| 2023 | Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon Cancer | CLINICAL COLORECTAL CANCER |
| 2021 | Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady-State Pharmacokinetics of Vemurafenib in Patients With BRAFV600 Mutation-Positive Malignancies | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2019 | Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients
| Frontiers in Oncology |
| 2016 | Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers | BRITISH JOURNAL OF CANCER |
| 2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2013 | Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation | JOURNAL OF ENDOVASCULAR THERAPY |
| 2020 | Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy | CLINICAL CANCER RESEARCH |
| 2011 | Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis | ONCOLOGY |
| 2022 | Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure | EUROPEAN JOURNAL OF CANCER |
| 2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | JOURNAL OF SURGICAL ONCOLOGY |
| 2024 | Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma
| ONCOLOGIST |
| 2022 | Feasibility of using dental putty-based custom molds for high-dose-rate brachytherapy of oral mucosal melanoma | PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS |
| 2021 | Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
| CANCER RESEARCH AND TREATMENT |
| 2022 | First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study. | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
| 2023 | Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers
| FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY |
| 2018 | Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
| CANCER RESEARCH AND TREATMENT |
| 2023 | Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study – (NCT05103020) – study protocol
| BMC CANCER |
| 2014 | High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2017 | IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
| NATURE COMMUNICATIONS |
| 2018 | IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors. | CANCER IMMUNOLOGY RESEARCH |
| 2023 | Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study
| CANCER RESEARCH AND TREATMENT |
| 2013 | Impact of Atorvastatin Treatment in First-Degree Relatives of Patients With Premature Coronary Artery Disease With Endothelial Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial | CLINICAL CARDIOLOGY |
| 2016 | Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2012 | Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer | SURGICAL ONCOLOGY-OXFORD |
| 2023 | Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer | ANNALS OF SURGERY |
| 2015 | Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
| CANCER RESEARCH AND TREATMENT |
| 2015 | Incorporation of radiotherapy in the multidisciplinary treatment of isolated retroperitoneal lymph node recurrence from colorectal cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2017 | Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
| CANCER RESEARCH AND TREATMENT |
| 2022 | KS10076, a chelator for redox-active metal ions, induces ROS-mediated STAT3 degradation in autophagic cell death and eliminates ALDH1 + stem cells
| CELL REPORTS |
| 2023 | Machine Learning-Based Mortality Prediction Model for Critically Ill Cancer Patients Admitted to the Intensive Care Unit (CanICU)
| CANCERS |
| 2020 | Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
| 2018 | Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2023 | Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease
| FRONTIERS IN ONCOLOGY |
| 2022 | Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer | CLINICAL COLORECTAL CANCER |
| 2008 | Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer | CANCER LETTERS |
| 2021 | Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection
| WORLD ALLERGY ORGANIZATION JOURNAL |
| 2015 | Novel methods for clinical risk stratification in patients with colorectal liver metastases
| CANCER RESEARCH AND TREATMENT |
| 2024 | Nuclear Localization of Yes-Associated Protein Is Associated With Tumor Progression in Cutaneous Melanoma
| LABORATORY INVESTIGATION |
| 2020 | Objectively measured physical activity during chemotherapy in colon cancer patients | SUPPORTIVE CARE IN CANCER |
| 2017 | Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition | ONCOGENE |
| 2020 | Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma | EUROPEAN JOURNAL OF CANCER |
| 2021 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
| JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
| PALLIATIVE MEDICINE REPORTS |
| 2022 | Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07 | JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2021 | Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
| YONSEI MEDICAL JOURNAL |
| 2023 | Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
| JOURNAL OF CLINICAL ONCOLOGY |
| 2024 | Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial
| EUROPEAN UROLOGY |
| 2012 | Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer | EUROPEAN RADIOLOGY |
| 2022 | Periodontal disease and cancer risk: A nationwide population-based cohort study
| FRONTIERS IN ONCOLOGY |
| 2013 | Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2020 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
| BRITISH JOURNAL OF CANCER |
| 2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2023 | Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
| ESMO OPEN |
